Gene · 3913
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tunable Synthesis of Hydrogel Microfibers via Interfacial Tetrazine Ligation. | Biomacromolecules | 2022 | 35737940 | PubTator, text mining | PubMed |
| Laminin 511-E8 Fragment Offers Superior Adhesion Properties for Gastric Cancer Cells Compared with Full-Length Laminin 511. | Curr Issues Mol Biol | 2022 | 35723363 | PubTator, text mining | PubMed |
| RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | 35720121 | PubTator, text mining | PubMed |
Gene Coexpression Network Characterizing Microenvironmental Heterogeneity and Intercellular Communication in Pancreatic Ductal Adenocarcinoma: Implications of Prognostic Significance and Therapeutic Target. | Front Oncol | 2022 | 35719923 | PubTator, text mining | PubMed |
| Knockdown of LMNB1 Inhibits the Proliferation of Lung Adenocarcinoma Cells by Inducing DNA Damage and Cell Senescence. | Front Oncol | 2022 | 35712471 | PubTator, text mining | PubMed |
| Isolated steroid-resistant nephrotic syndrome in a Chinese child carrying a de novo mutation in WT1 gene:a case report and literature review. | BMC Pediatr | 2022 | 35710404 | PubTator, text mining | PubMed |
| Interplay between Solid Tumors and Tumor Microenvironment. | Front Immunol | 2022 | 35707536 | PubTator, text mining | PubMed |
| miR-218 affects the ECM composition and cell biomechanical properties of glioblastoma cells. | J Cell Mol Med | 2022 | 35702951 | PubTator, text mining | PubMed |
| Inter-donor variability of extracellular matrix production in long-term cultures of human fibroblasts. | Biomater Sci | 2022 | 35700514 | PubTator, text mining | PubMed |
| High-efficient serum-free differentiation of endothelial cells from human iPS cells. | Stem Cell Res Ther | 2022 | 35690874 | PubTator, text mining | PubMed |
| PEAK1 Y635 phosphorylation regulates cell migration through association with Tensin3 and integrins. | J Cell Biol | 2022 | 35687021 | PubTator, text mining | PubMed |
| A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease. | Kidney Int Rep | 2022 | 35685307 | PubTator, text mining | PubMed |
| Correction: Park et al. Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. J. Clin. Med. 2020, 9, 2013. | J Clin Med | 2022 | 35683636 | PubTator, text mining | PubMed |
| Mechanisms during Osteogenic Differentiation in Human Dental Follicle Cells. | Int J Mol Sci | 2022 | 35682637 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Corneal Fibrosis/Scarring. | Int J Mol Sci | 2022 | 35682600 | PubTator, text mining | PubMed |
| Proteomic Analysis of Lung Cancer Types-A Pilot Study. | Cancers (Basel) | 2022 | 35681609 | PubTator, text mining | PubMed |
| Efficient generation of functional pancreatic β cells from dental-derived stem cells via laminin-induced differentiation. | J Genet Eng Biotechnol | 2022 | 35674918 | PubTator, text mining | PubMed |
| The Four Key Genes Participated in and Maintained Atrial Fibrillation Process via Reprogramming Lipid Metabolism in AF Patients. | Front Genet | 2022 | 35669184 | PubTator, text mining | PubMed |
| A 3D-printed scaffold-based osteosarcoma model allows to investigate tumor phenotypes and pathogenesis in an in vitro bone-mimicking niche. | Mater Today Bio | 2022 | 35665234 | PubTator, text mining | PubMed |
| Recessive LAMA5 Variants Associated With Partial Epilepsy and Spasms in Infancy. | Front Mol Neurosci | 2022 | 35663266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/papers?page=45